Search Results

Deferiprone: greater efficacy at depleting myocardial than hepatic iron?

• Authors : Richardson DR (AUTHOR); Richardson, Des R¹ (AUTHOR)

• Source: Lancet. 8/17/2002, Vol. 360 Issue 9332, p501-502. 2p.

Record details

Sickle-cell disease.

• Authors : Stuart MJ (AUTHOR); Nagel RL (AUTHOR)

• Source: Lancet. 10/9/2004, Vol. 364 Issue 9442, p1343-1360. 18p.

Record details

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

• Authors : Nisbet-Brown E (AUTHOR); Olivieri NF (AUTHOR); Giardina PJ (AUTHOR)

• Source: Lancet. 5/10/2003, Vol. 361 Issue 9369, p1597-1602. 6p.

Record details

CORRESPONDENCE.

Subjects: PHYSICIANS' correspondence; ORAL diseases; RECOMBINANT DNA

• Source: Lancet. 10/21/2000, Vol. 356 Issue 9239, p1437. 10p. 2 Black and White Photographs, 1 Chart.

Record details

Cystic fibrosis.

• Authors : Rosenstein, Beryl J.; Zeitlin, Pamela L.

Subjects: CYSTIC fibrosis

• Source: Lancet. 1/24/1998, Vol. 351 Issue 9098, p277. 6p. 3 Diagrams.

Record details

Transfusion requirements and effects in patients with thalassaemia major.

• Authors : Rebulla, P.; Modell, B.

Subjects: BLOOD transfusion

• Source: Lancet. 2/2/1991, Vol. 337 Issue 8736, p277. 4p. 7 Graphs.

Record details

Assisted dying for the terminally ill.

• Authors : Johnson IS (AUTHOR); Johnson, Ian S (AUTHOR)

• Source: Lancet. 10/22/2005, Vol. 366 Issue 9495, p1433-1434. 2p.

Record details

Deferiprone for thalassaemia.

• Authors : Pippard, M J (AUTHOR); Weatherall, D J (AUTHOR)

Subjects: *ORAL drug administration; *PYRIDINE; *THALASSEMIA

• Source: Lancet. 10/21/2000, Vol. 356 Issue 9239, p1444-1445. 2p.

Record details

Academia and industry: lessons from the unfortunate events in Toronto.

• Authors : Nathan, D.G.; Weatherall, D.J.

Subjects: *SCIENCE & industry; *SCIENCE & ethics; *CLINICAL trials & ethicsONTARIO; TORONTO (Ont.); CANADA

• Source: Lancet. 3/6/1999, Vol. 353 Issue 9155, p771-772. 2p.

Record details

Arthropathy in thalassaemia patients receiving deferiprone.

• Authors : Berkovitch, Matitiahu; Laxer, Ronald M; al, et

Subjects: *IRON chelates; *THALASSEMIA; *DRUG therapy

• Source: Lancet. 6/11/1994, Vol. 343 Issue 8911, p1471. 2p.

Record details